The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrakm8 Hldgs Regulatory News (TRAK)

Share Price Information for Trakm8 Hldgs (TRAK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
TRAK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Belgravium Technologies PLC

9 Jul 2014 11:15

RNS Number : 8544L
Belgravium Technologies PLC
09 July 2014
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Belgravium Technologies PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Belgravium Technologies PLC

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

8 July 2014

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

The interests of the directors of Belgravium Technologies PLC in the ordinary shares of 5 pence each ("Ordinary Shares") are as follows:

 

J Kembery

9,211,269

9.13%

M Hardy

510,000

0.51%

M Unwin

300,000

0.30%

C Phillips

165,000

0.16%

 

WH Ireland (connected adviser to offeree) has an interest in 100,000 (0.10%) Ordinary Shares held on behalf of discretionary clients.

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

9 July 2014

Contact name:

Mike Coe

Telephone number:

0117 945 3470

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEBKLFBZDFBBBV
Date   Source Headline
3rd Apr 20247:00 amRNSTrading Update, Contract Extension & CLNs Issue
22nd Mar 20247:00 amRNSTrading update
24th Nov 20237:00 amRNSHalf-year Report
15th Nov 20239:37 amRNSDirectorate Change
7th Nov 20239:46 amRNSHolding(s) in Company
21st Sep 202311:13 amRNSResult of Annual General Meeting (AGM)
21st Sep 20237:00 amRNSAGM Statement & Trading Update
25th Aug 20237:00 amRNSNotice of AGM and Capital Markets Day
7th Jul 202311:18 amRNSAward of options
4th Jul 20237:00 amRNSFinal Results
25th Apr 20237:00 amRNSYear End Trading Update
20th Apr 20237:00 amRNSContract Award
30th Mar 20237:00 amRNSIceland Foods Awards Contract Extension
29th Mar 20237:00 amRNSSainsbury’s Awards Optimisation Contract Extension
28th Mar 20237:00 amRNSContract Award
22nd Feb 20237:00 amRNSCapital Markets Day
15th Dec 20228:05 amRNSAward of Options
8th Dec 20227:00 amRNSHalf Year Results
28th Nov 202211:58 amRNSDirector Dealing
22nd Sep 202210:46 amRNSResult of Annual General Meeting (AGM)
22nd Sep 20227:00 amRNSAGM Statement & Trading Update
14th Sep 20228:00 amRNSTrading and Strategy Update and Issue of CLN
18th Aug 20227:00 amRNSNotice of AGM
22nd Jul 20227:00 amRNSCompletion of Nominated Adviser due diligence
6th Jul 20227:00 amRNSContract Award
29th Jun 20227:00 amRNSFinal Results
27th Apr 20222:00 pmRNSChange of Nominated Adviser and Broker
26th Apr 20227:00 amRNSTrading Update
29th Mar 20227:00 amRNSContract Extension
22nd Mar 20227:00 amRNSContract Award
18th Mar 20227:00 amRNSContract Extension
2nd Dec 20217:00 amRNSContract Award
19th Nov 20213:57 pmRNSAward of Options
16th Nov 20217:00 amRNSHalf Year Results and Director Change
1st Oct 20217:00 amRNSAppointment of Director
27th Sep 20217:00 amRNSAward of Green Economy Mark
23rd Sep 202111:00 amRNSResult of Annual General Meeting (AGM)
23rd Sep 20217:00 amRNSAGM Statement & Trading Update
19th Aug 20212:33 pmRNSNotice of Annual General Meeting
13th Jul 20217:00 amRNSAward of options
12th Jul 20217:00 amRNSDirectorate Change
29th Jun 20217:00 amRNSFinal Results
22nd Jun 20217:00 amRNSNotice of Results
28th Apr 20217:00 amRNSYear End Trading Update
12th Mar 20217:00 amRNSDirector Dealings
25th Feb 20217:00 amRNSContract Award and Trading Update
30th Nov 20207:00 amRNSIssue of Options
23rd Nov 20207:00 amRNSHalf-Year Results
17th Sep 202010:00 amRNSResult of AGM
17th Sep 20207:00 amRNSChairman's Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.